EP Patent

EP1111390A4 — Method for evaluating lipid a analog-containing injections

Assigned to Eisai R&D Management Co Ltd · Expires 2007-11-14 · 19y expired

What this patent protects

A method for evaluating injections containing lipid A analogs and a process for producing these injections. With respect to injection preparations containing lipid A analogs or pharmacologically acceptable salts thereof, namely, a method for predicting the dynamics of the lipid A…

USPTO Abstract

A method for evaluating injections containing lipid A analogs and a process for producing these injections. With respect to injection preparations containing lipid A analogs or pharmacologically acceptable salts thereof, namely, a method for predicting the dynamics of the lipid A analogs in vivo, a method for evaluating the same, a method for evaluating the qualities of the injections or a process for producing the injections, each characterized by measuring the membrane fluidity and/or circular polarization.

Drugs covered by this patent

Patent Metadata

Patent number
EP1111390A4
Jurisdiction
EP
Classification
—
Expires
2007-11-14
Drug substance claim
No
Drug product claim
No
Assignee
Eisai R&D Management Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.